British drug developer GW Pharmaceuticals Plc said its experimental cannabis-derived epilepsy drug met the main goal to reduce frequency of seizures in a late-stage study.
Princeton, New Jersey-based Bristol-Myers Squibb announced that its drug Opdivo had been granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration for the treatment of unresectable locally advanced or metastatic urothelial carcinoma that has progressed on or after a platinum-based chemotherapy regimen.
Paris-based Sanofi and Germany-based Boehringer Ingelheim have agreed to exchange Sanofi’s Merial animal drugs business with Boehringer’s over-the-counter drugs business.
Drug developer Allergy Therapeutics Plc said a study on suitable doses of its therapy to treat grass allergic rhinitis, or hay fever, did not find a recommended dose for a late-stage trial.
FCB Health along with the FCB network brought home nine top awards at the 2016 Lions Health awards, part of the Cannes Lions International Festival of Creativity.
An FDA advisory panel will be asked to vote on whether a diabetes drug made by Eli Lilly and Boehringer Ingelheim cuts the risk of cardiovascular death, according to the agency’s website.
Britain’s vote to leave the European Union spells regulatory uncertainty for drug companies, with the London-based European Medicines Agency (EMA) expected to have to relocate.
Shares of AstraZeneca are down more than 5 percent in early trading and shares of GlaxoSmithKline have slipped more than 4 percent hours after a slight majority of Britons voted to exit the European Union. Both companies have been on record as preferring to remain within the E.U.
Takeda Pharmaceutical is returning some molecules and products to Amgen it had access to through a collaboration agreement that yielded a cancer treatment for the Japanese market.
The White House threatened to veto the $1.1 billion approved by the U.S. House of Representatives to fight the Zika virus, blasting the measure for short-changing the administration’s $1.9 billion funding request.